Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Eiki IchiharaNobuaki OchiGo MakimotoKenichiro KudoDaijiro HaradaYukinori OzakiHiroshi NishioKenji TsuchihashiYuji MiuraMakoto EndoShingo YanoDai MaruyamaTetsuhiro YoshinamiNobuyuki SusumuMunetaka TakekumaTakashi MotohashiMamoru ItoEishi BabaKeita UchinoTakahiro KimuraYutaro KamiyamaShinji NakaoShinobu TamuraHitomi NishimotoYasuhisa KatoAtsushi SatoToshimi TakanoToshio KuboPublished in: International journal of clinical oncology (2024)
Limited data are available on G-CSF prophylaxis in lung cancer. Primary prophylaxis with G-CSF may be weakly recommended in Japanese patients with NSCLC undergoing docetaxel and ramucirumab combination therapy.